BPG is committed to discovery and dissemination of knowledge
Correspondence
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Surg. Apr 27, 2026; 18(4): 115868
Published online Apr 27, 2026. doi: 10.4240/wjgs.v18.i4.115868
Letter to the Editor: DAF-FM fluorescent probe: Advancing early detection of esophagitis-to-cancer transformation through nitric oxide imaging
Sachin Namdeo Kothawade, Vijaya Padwal
Sachin Namdeo Kothawade, Vijaya Padwal, Department of Pharmaceutics, SCSSS’s Sitabai Thite College of Pharmacy, Shirur 412210, Maharashtra, India
Co-first authors: Sachin Namdeo Kothawade and Vijaya Padwal.
Author contributions: Kothawade SN was responsible for conceptualization; critical analysis of the original study, drafting of the manuscript, development of the translational framework, literature review, and manuscript revision; Padwal V was responsible for co-conceptualization, interpretation of mechanistic and clinical relevance, drafting specific sections related to nitric oxide biology and imaging, reference validation; manuscript editing and refinement; both authors have made crucial contributions to the completion of the manuscript as co-first authors; all authors have read and approved the final manuscript and agree to be accountable for all aspects of the work.
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
Corresponding author: Sachin Namdeo Kothawade, PhD, Professor, Research Dean, Department of Pharmaceutics, SCSSS’s Sitabai Thite College of Pharmacy, Ghodnadi, Shirur 412210, Maharashtra, India. sachin.kothawade23@gmail.com
Received: October 27, 2025
Revised: November 26, 2025
Accepted: February 12, 2026
Published online: April 27, 2026
Processing time: 179 Days and 4.1 Hours
Abstract

Chen et al published a study in the recent issue of World Journal of Gastrointestinal Surgery evaluated the high-performance fluorescent probe DAF-FM provides a significant advancement in early esophageal cancer detection. DAF-FM enables real-time monitoring of nitric oxide during esophagitis-to-cancer transformation, with concentration-dependent and time-dependent fluorescence, lysosomal targeting, and low cytotoxicity. In preclinical models, DAF-FM fluorescence strongly correlates with tumor volume (R² = 0.87) and demonstrates superior sensitivity compared to endoscopic biopsy. These findings position DAF-FM as a rapid, non-invasive, and clinically relevant tool for early diagnosis and treatment monitoring in high-risk esophagitis patients.

Keywords: DAF-FM; Fluorescent probe; Nitric oxide; Esophagitis; Early detection; Molecular imaging; Esophageal cancer; Translational research

Core Tip: This letter highlights the translational potential of DAF-FM for visualizing nitric oxide dynamics in esophagitis-to-cancer progression. By bridging molecular pathophysiology and clinical imaging, DAF-FM could enhance early detection, improve personalized therapy monitoring, and expedite the translation of molecular insights into practical clinical applications.